Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Anti-JC virus (JCV) antibody prevalence in the JCV Epidemiology in MS (JEMS) trial.
Health effects of lesion localization in multiple sclerosis: spatial registration and confounding adjustment.
[A review of multiple sclerosis (1). Presentation of a case.]
Physical Activity in Multiple Sclerosis: A Comparative Study of Vitamin D, Brain-Derived Neurotrophic Factor and Regulatory T Cell Populations.
Unusual Manifestations of Pediatric Neuromyelitis Optica.
[Update of the treatment of multiple sclerosis].
No evidence of a link between multiple sclerosis and the vaccine against the human papillomavirus.
Seizure characteristics in multiple sclerosis patients.
Demyelinating disorders secondary to TNF-inhibitor therapy for the treatment of psoriasis: A review.
Comparison of quality of life between two clinical conditions with immunosuppressive therapy: liver transplantation and multiple sclerosis.
Malt1-dependent RelB cleavage promotes canonical NF-kappaB activation in lymphocytes and lymphoma cell lines.
S1P and the birth of platelets.
Renal deterioration in multiple sclerosis patients with neurovesical dysfunction.
[The effect of genetic factors on the phenotypic expression of multiple sclerosis.]
Adapted exercise interventions for persons with progressive multiple sclerosis.
Combining Self-help and Professional Help to Minimize Barriers to Physical Activity in Persons With Multiple Sclerosis: A Trial of the "Blue Prescription" Approach in New Zealand.
Feature Selection in Order to Extract Multiple Sclerosis Lesions Automatically in 3D Brain Magnetic Resonance Images Using Combination of Support Vector Machine and Genetic Algorithm.
Autoantibodies to neurofascin-186 and gliomedin in multifocal motor neuropathy.
Goal attainment in cognitive rehabilitation in MS patients.
Facial and Bodily Emotion Recognition in Multiple Sclerosis: The Role of Alexithymia and Other Characteristics of the Disease.
Neurofascin 140 is an embryonic neuronal neurofascin isoform that promotes the assembly of the node of ranvier.
Oral drugs in multiple sclerosis therapy: an overview and a critical appraisal.
Are ERM (ezrin/radixin/moesin) proteins targets for autoantibodies in demyelinating neuropathies?
Prolactin: A versatile regulator of inflammation and autoimmune pathology.
Cardiovascular risk factors are associated with increased lesion burden and brain atrophy in multiple sclerosis.
Pages
« first
‹ previous
…
433
434
435
436
437
438
439
440
441
…
next ›
last »